Sherbrooke Park Advisers LLC Mirum Pharmaceuticals, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 6,355 shares of MIRM stock, worth $337,831. This represents 0.08% of its overall portfolio holdings.
Number of Shares
6,355
Previous 6,779
6.25%
Holding current value
$337,831
Previous $264 Million
0.61%
% of portfolio
0.08%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$349 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$244 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$172 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$149 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$139 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.95B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...